Dashboard
Manage Tickers

XBIO Xenetic Biosciences, Inc.

Nasdaq xeneticbio.com


$ 3.40 $ 0.05 (1.52 %)    

Friday, 31-Oct-2025 18:00:40 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 629.13 $ 3.02 (0.48 %)
DIA $ 475.66 $ 0.66 (0.14 %)
SPY $ 682.17 $ 2.23 (0.33 %)
TLT $ 90.29 $ -0.27 (-0.3 %)
GLD $ 368.13 $ -2.01 (-0.54 %)
$ 3.34
$ 3.29
$ 3.28 x 12
$ 3.40 x 50
$ 3.26 - $ 3.45
$ 2.20 - $ 13.93
58,411
na
5.07M
$ 0.85
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-12-2025 06-30-2025 10-Q
2 05-13-2025 03-31-2025 10-Q
3 03-18-2025 12-31-2024 10-K
4 11-12-2024 09-30-2024 10-Q
5 08-13-2024 06-30-2024 10-Q
6 05-09-2024 03-31-2024 10-Q
7 03-21-2024 12-31-2023 10-K
8 11-09-2023 09-30-2023 10-Q
9 08-10-2023 06-30-2023 10-Q
10 05-11-2023 03-31-2023 10-Q
11 03-22-2023 12-31-2022 10-K
12 11-09-2022 09-30-2022 10-Q
13 08-11-2022 06-30-2022 10-Q
14 05-12-2022 03-31-2022 10-Q
15 03-22-2022 12-31-2021 10-K
16 11-12-2021 09-30-2021 10-Q
17 08-12-2021 06-30-2021 10-Q
18 05-11-2021 03-31-2021 10-Q
19 03-16-2021 12-31-2020 10-K
20 11-12-2020 09-30-2020 10-Q
21 08-12-2020 06-30-2020 10-Q
22 05-14-2020 03-31-2020 10-Q
23 03-26-2020 12-31-2019 10-K
24 11-14-2019 09-30-2019 10-Q
25 08-14-2019 06-30-2019 10-Q
26 05-13-2019 03-31-2019 10-Q
27 03-29-2019 12-31-2018 10-K
28 11-09-2018 09-30-2018 10-Q
29 08-10-2018 06-30-2018 10-Q
30 05-15-2018 03-31-2018 10-Q
31 03-30-2018 12-31-2017 10-K
32 11-14-2017 09-30-2017 10-Q
33 08-14-2017 06-30-2017 10-Q
34 05-15-2017 03-31-2017 10-Q
35 03-31-2017 12-31-2016 10-K
36 11-14-2016 09-30-2016 10-Q
37 08-15-2016 06-30-2016 10-Q
38 05-16-2016 03-31-2016 10-Q
39 03-30-2016 12-31-2015 10-K
40 11-16-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

micron-galecto-and-xenetic-lead-this-weeks-benzinga-stock-ranking-surges
Micron, Galecto And Xenetic Lead This Week...
10/10/2025 20:44:36

Benzinga Edge Stock Rankings evaluate companies across four key factors. Here are three big companies that stood out this week.

Core News & Articles
12 Health Care Stocks Moving In Friday's I...
10/10/2025 17:06:47

xenetic-biosciences-prices-offering-of-735k-common-shares-at-612shr-for-gross-proceeds-of-45m
Xenetic Biosciences Prices Offering Of 735...
10/10/2025 13:33:11

Xenetic Biosciences, Inc. (NASDAQ:XBIO) ("Xenetic" or the "Company"), a biopharmaceutical company focused on ad...

4-stocks-in-the-same-sector-just-made-a-huge-leap-in-momentum-rankings
4 Stocks In The Same Sector Just Made A Hu...
10/09/2025 15:12:28

Healthcare and biotech stocks have lagged broader markets this year, but a growing number of names have been picking up steam a...

why-richardson-electronics-shares-are-trading-higher-by-over-20-here-are-20-stocks-moving-premarket
Why Richardson Electronics Shares Are Trad...
10/09/2025 09:12:11

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
10/08/2025 17:06:09

nasdaq-gains-150-points-us-mortgage-applications-decline
Nasdaq Gains 150 Points; US Mortgage Appli...
10/08/2025 14:22:35

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
10/08/2025 12:09:23

why-confluent-shares-are-trading-higher-by-around-20-here-are-20-stocks-moving-premarket
Why Confluent Shares Are Trading Higher By...
10/08/2025 08:43:58

xenetic-biosciences-q2-eps-045-beats-065-estimate-sales-589897k-miss-720000k-estimate
Xenetic Biosciences Q2 EPS $(0.45) Beats $...
08/13/2025 12:09:33

Xenetic Biosciences (NASDAQ:XBIO) reported quarterly losses of $(0.45) per share which beat the analyst consensus estimate of $...

xenetic-biosciences-collaboration-partner-periness-enters-clinical-study-agreement-to-support-exploratory-study-of-dnase-i-plus-anti-cd19-car-t-cells-in-large-b-cell-lymphoma-patients
Xenetic Biosciences Collaboration Partner ...
07/30/2025 13:02:33

xenetic-biosciences-expands-rd-collaboration-with-scripps-research-institute-to-advance-the-dnase-platform
Xenetic Biosciences Expands R&D Collaborat...
07/23/2025 12:40:32

xenetic-biosciences-announces-first-patient-dosing-in-exploratory-clinical-study-of-systemic-dnase-i-in-combination-with-folfirinox-for-advanced-or-metastatic-pancreatic-cancer
Xenetic Biosciences Announces First Patien...
07/08/2025 13:04:23

Investigator initiated exploratory clinical study being conducted in Israel pursuant to agreement with collaboration partner, P...

Core News & Articles
12 Health Care Stocks Moving In Monday's A...
06/30/2025 21:06:29

Core News & Articles
12 Health Care Stocks Moving In Monday's A...
06/23/2025 21:06:48

xenetic-biosciences-q1-eps-059-beats-072-estimate-sales-59326k-miss-67000k-estimate
Xenetic Biosciences Q1 EPS $(0.59) Beats $...
05/13/2025 21:58:59

Xenetic Biosciences (NASDAQ:XBIO) reported quarterly losses of $(0.59) per share which beat the analyst consensus estimate of $...

hc-wainwright--co-reiterates-neutral-on-xenetic-biosciencesto-neutral
HC Wainwright & Co. Reiterates Neutral on ...
04/09/2025 16:46:28

HC Wainwright & Co. analyst Joseph Pantginis reiterates Xenetic Biosciences (NASDAQ:XBIO) from Neutral to Neutral.

hc-wainwright--co-reiterates-neutral-on-xenetic-biosciencesto-neutral
HC Wainwright & Co. Reiterates Neutral on ...
03/20/2025 15:18:02

HC Wainwright & Co. analyst Joseph Pantginis reiterates Xenetic Biosciences (NASDAQ:XBIO) from Neutral to Neutral.

xenetic-biosciences-q4-eps-068-misses-020-estimate-sales-64882k-beat-23000k-estimate
Xenetic Biosciences Q4 EPS $(0.68) Misses ...
03/19/2025 12:26:45

Xenetic Biosciences (NASDAQ:XBIO) reported quarterly losses of $(0.68) per share which missed the analyst consensus estimate of...

xenetic-biosciences-net-loss-for-the-year-ended-december-31-2024-was-4m-ended-the-year-with-62m-of-cash
Xenetic Biosciences Net Loss For The Year ...
03/19/2025 12:20:00

Summary of Financial Results for Fiscal Year 2024Net loss for the year ended December 31, 2024 was approximately $4.0 million. ...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION